Skip to main content
. 2013 Mar 5;8(3):e58580. doi: 10.1371/journal.pone.0058580

Figure 5. Fluorescein angiography 2 weeks after CNV laser procedure.

Figure 5

(A) Representative results of fluorescein angiography in each group at 2 weeks after CNV laser procedure. The groups were treated with NVDD (a), VDD (b), 10VDD (c), vasohibin-1 pellet (d), intravitreal vehicle injection (Vehicle iv) (e), intravitreal vasohibin-1 injection (Vasohibin-1 iv) (f). (B) Significantly lower FA scores was shown in the Vasohibin-1 iv group when compared to those of NVDD (p = 0.000022), and Vehicle iv (p = 0.0065). Significantly lower FA scores are also observed in the 10VDD group when compared to the NVDD group (p = 0.00003) and intravitreal vehicle injection (p = 0.011). Significant differences are shown as asterisks. NVDD: non-vasohibin-1 (vehicle) delivery device, VDD: 1 μM vasohibin-1 delivery device, 10VDD: 10 μM vasohibin-1 delivery device, Pellets: vasohibin-1 pelletized at the same concentration of 10VDD (without reservoir and cover).